DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer

Abstract

The objective of this research was to develop a robust gene expression-based prognostic signature and scoring system for predicting overall survival (OS) of patients with high-grade serous ovarian cancer (HGSOC). Transcriptomic data of HGSOC patients were obtained from six independent studies in the NCBI GEO database. Genes significantly deregulated and associated with OS in HGSOCs were selected using GEO2R and Kaplan–Meier analysis with log-rank testing, respectively. Enrichment analysis for biological processes and pathways was performed using Gene Ontology analysis. A resampling/cross-validation method with Cox regression analysis was used to identify a novel gene expression-based signature associated with OS, and a prognostic scoring system was developed and further validated in nine independent HGSOC datasets. We first identified 488 significantly deregulated genes in HGSOC patients, of which 232 were found to be significantly associated with their OS. These genes were significantly enriched for cell cycle division, epithelial cell differentiation, p53 signaling pathway, vasculature development, and other processes. A novel 11-gene prognostic signature was identified and a prognostic scoring system was developed, which robustly predicted OS in HGSOC patients in 100 sampling test sets. The scoring system was further validated successfully in nine additional HGSOC public datasets. In conclusion, our integrative bioinformatics studymore » combining transcriptomic and clinical data established an 11-gene prognostic signature for robust and reproducible prediction of OS in HGSOC patients. This signature could be of clinical value for guiding therapeutic selection and individualized treatment.« less

Authors:
 [1];  [2];  [3];  [4];  [5];  [6];  [6]; ORCiD logo [7]; ORCiD logo [6]
  1. Nanjing Medical Univ. (China); Peking Univ. Third Hospital, Beijing (China)
  2. Peking Univ. Health Science Center, Beijing (China)
  3. Beijing Maternal and Child Health Care Hospital (China)
  4. The Third Affiliated Hospital of Chongqing Medical Univ., Chongqing (China)
  5. Nanjing Univ. Medical School, Jiangsu (China)
  6. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  7. Peking Univ. Third Hospital, Beijing (China)
Publication Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC); National Key Research and Development Program for Reproductive Health and Major Birth Defects Control and Prevention; China Scholarship Council
OSTI Identifier:
1599791
Grant/Contract Number:  
AC02-05CH11231; 2017YFC1002004; 201606010313
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Oncology
Additional Journal Information:
Journal Volume: 2019; Journal ID: ISSN 1687-8450
Publisher:
Hindawi
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Zhao, Yue, Yang, Shao-Min, Jin, Yu-Lan, Xiong, Guang-Wu, Wang, Pin, Snijders, Antoine M., Mao, Jian-Hua, Zhang, Xiao-Wei, and Hang, Bo. A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer. United States: N. p., 2019. Web. doi:10.1155/2019/3614207.
Zhao, Yue, Yang, Shao-Min, Jin, Yu-Lan, Xiong, Guang-Wu, Wang, Pin, Snijders, Antoine M., Mao, Jian-Hua, Zhang, Xiao-Wei, & Hang, Bo. A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer. United States. https://doi.org/10.1155/2019/3614207
Zhao, Yue, Yang, Shao-Min, Jin, Yu-Lan, Xiong, Guang-Wu, Wang, Pin, Snijders, Antoine M., Mao, Jian-Hua, Zhang, Xiao-Wei, and Hang, Bo. Thu . "A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer". United States. https://doi.org/10.1155/2019/3614207. https://www.osti.gov/servlets/purl/1599791.
@article{osti_1599791,
title = {A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer},
author = {Zhao, Yue and Yang, Shao-Min and Jin, Yu-Lan and Xiong, Guang-Wu and Wang, Pin and Snijders, Antoine M. and Mao, Jian-Hua and Zhang, Xiao-Wei and Hang, Bo},
abstractNote = {The objective of this research was to develop a robust gene expression-based prognostic signature and scoring system for predicting overall survival (OS) of patients with high-grade serous ovarian cancer (HGSOC). Transcriptomic data of HGSOC patients were obtained from six independent studies in the NCBI GEO database. Genes significantly deregulated and associated with OS in HGSOCs were selected using GEO2R and Kaplan–Meier analysis with log-rank testing, respectively. Enrichment analysis for biological processes and pathways was performed using Gene Ontology analysis. A resampling/cross-validation method with Cox regression analysis was used to identify a novel gene expression-based signature associated with OS, and a prognostic scoring system was developed and further validated in nine independent HGSOC datasets. We first identified 488 significantly deregulated genes in HGSOC patients, of which 232 were found to be significantly associated with their OS. These genes were significantly enriched for cell cycle division, epithelial cell differentiation, p53 signaling pathway, vasculature development, and other processes. A novel 11-gene prognostic signature was identified and a prognostic scoring system was developed, which robustly predicted OS in HGSOC patients in 100 sampling test sets. The scoring system was further validated successfully in nine additional HGSOC public datasets. In conclusion, our integrative bioinformatics study combining transcriptomic and clinical data established an 11-gene prognostic signature for robust and reproducible prediction of OS in HGSOC patients. This signature could be of clinical value for guiding therapeutic selection and individualized treatment.},
doi = {10.1155/2019/3614207},
journal = {Journal of Oncology},
number = ,
volume = 2019,
place = {United States},
year = {Thu Nov 07 00:00:00 EST 2019},
month = {Thu Nov 07 00:00:00 EST 2019}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 4 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
journal, December 2013


Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer
journal, January 2018


MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion
journal, January 2018

  • Lin, Hao ; Huang, Bin; Wang, Hua
  • Cellular Physiology and Biochemistry, Vol. 51, Issue 2
  • DOI: 10.1159/000495402

A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
journal, July 2008


Sorting Nexin 1 Down-Regulation Promotes Colon Tumorigenesis
journal, December 2006


Integrative network analysis of TCGA data for ovarian cancer
journal, December 2014


Expression of Tumor-rejection Antigens in Gynecologic Cancers
journal, November 2000


Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
journal, September 2014

  • Konecny, Gottfried E.; Wang, Chen; Hamidi, Habib
  • JNCI: Journal of the National Cancer Institute, Vol. 106, Issue 10
  • DOI: 10.1093/jnci/dju249

Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
journal, January 2017

  • Ata, Rehman; Antonescu, Costin
  • International Journal of Molecular Sciences, Vol. 18, Issue 1
  • DOI: 10.3390/ijms18010189

Pathogenesis and heterogeneity of ovarian cancer
journal, January 2017


ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
journal, February 2009


Prognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma
journal, January 2017


New insights into ovarian cancer pathology
journal, September 2012


A robust gene expression-based prognostic risk score predicts overall survival of lung adenocarcinoma patients
journal, December 2017


Ovarian Low-grade and High-grade Serous Carcinoma: Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
journal, January 2009


Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
journal, January 2012

  • Győrffy, Balázs; Lánczky, András; Szállási, Zoltán
  • Endocrine-Related Cancer, Vol. 19, Issue 2
  • DOI: 10.1530/erc-11-0329

The mitochondrial one‑carbon metabolic pathway is associated with patient survival in pancreatic cancer
journal, May 2018


Ovarian cancer
journal, August 2016

  • Matulonis, Ursula A.; Sood, Anil K.; Fallowfield, Lesley
  • Nature Reviews Disease Primers, Vol. 2, Issue 1
  • DOI: 10.1038/nrdp.2016.61

DyNet: visualization and analysis of dynamic molecular interaction networks
journal, May 2016


Epidemiology of ovarian cancer: a review
journal, January 2017


Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
journal, August 2008


Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues
journal, April 2013


Meta- and Orthogonal Integration of Influenza “OMICs” Data Defines a Role for UBR4 in Virus Budding
journal, December 2015


Integrated genomic analyses of ovarian carcinoma
journal, June 2011


Cancer statistics, 2017
journal, January 2017

  • Siegel, Rebecca L.; Miller, Kimberly D.; Jemal, Ahmedin
  • CA: A Cancer Journal for Clinicians, Vol. 67, Issue 1
  • DOI: 10.3322/caac.21387

A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma
journal, January 2016

  • Liu, Li-Wei; Zhang, Qiuhao; Guo, Wenna
  • BioMed Research International, Vol. 2016
  • DOI: 10.1155/2016/6945304

Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
journal, January 2018


A novel gene expression-based prognostic scoring system to predict survival in gastric cancer
journal, July 2016


A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
journal, March 2012


DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling
journal, June 2018


Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays
journal, February 2009

  • Ju, Woong; Yoo, Byong Chul; Kim, Il-Jin
  • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 18, Issue 2
  • DOI: 10.3727/096504009789954672

Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer
journal, August 2020

  • Kim, Ji-Yeon; Jung, Hae Hyun; Sohn, Insuk
  • Breast Cancer Research and Treatment, Vol. 184, Issue 2
  • DOI: 10.1007/s10549-020-05874-1

Thermal stress induces glycolytic beige fat formation via a myogenic state
journal, December 2018


Integrated genomic analyses of ovarian carcinoma
text, January 2011

  • Charles, Perou,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/hvp3-wg08

Ovarian Cancer: Histogenetic Classification, Histologic Grading, Diagnosis, Staging, and Epidemiology
journal, January 1985


Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues
journal, April 2013


A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
journal, March 2012


Integrated genomic analyses of ovarian carcinoma
journal, June 2011


Ovarian cancer
journal, August 2016

  • Matulonis, Ursula A.; Sood, Anil K.; Fallowfield, Lesley
  • Nature Reviews Disease Primers, Vol. 2, Issue 1
  • DOI: 10.1038/nrdp.2016.61

Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
journal, January 2018


Diagnostic classification of cancers using DNA methylation of paracancerous tissues
journal, June 2022


New insights into ovarian cancer pathology
journal, September 2012


DyNet: visualization and analysis of dynamic molecular interaction networks
journal, May 2016


Pathogenesis and heterogeneity of ovarian cancer
journal, January 2017


Expression of Tumor-rejection Antigens in Gynecologic Cancers
journal, November 2000


A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
journal, July 2008


Sorting Nexin 1 Down-Regulation Promotes Colon Tumorigenesis
journal, December 2006


MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion
journal, January 2018

  • Lin, Hao ; Huang, Bin; Wang, Hua
  • Cellular Physiology and Biochemistry, Vol. 51, Issue 2
  • DOI: 10.1159/000495402

Integrative network analysis of TCGA data for ovarian cancer
journal, December 2014


DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling
journal, June 2018


Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
journal, January 2012

  • Győrffy, Balázs; Lánczky, András; Szállási, Zoltán
  • Endocrine-Related Cancer, Vol. 19, Issue 2
  • DOI: 10.1530/erc-11-0329

A novel gene expression-based prognostic scoring system to predict survival in gastric cancer
journal, July 2016


Prognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma
journal, January 2017


Epidemiology of ovarian cancer: a review
journal, January 2017


Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays
journal, February 2009

  • Ju, Woong; Yoo, Byong Chul; Kim, Il-Jin
  • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 18, Issue 2
  • DOI: 10.3727/096504009789954672

Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer
journal, January 2018